Evidence map›Paper›PMID 35341332›Full record

ArticleInternational journal of immunopathology and pharmacology

Clinical and hematological characteristics of 300 COVID-19 patients in Erbil, Kurdistan Region, Iraq.

Rundk Ahmad Hwaiz, Sahar Mohammed Zaki Abdullah, Salah Tofik Jalal Balaky, Katan Sabir Ali, Mohammed Yousif Merza, Shakhawan Assad Khailani, Nazar Pauls Shabila

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Rundk Ahmad HwaizDepartment of Clinical Biochemistry, College of Health Sciences, 125618Hawler Medical University, Erbil, Iraq.ORCID https://orcid.org/0000-0002-2743-0807
Sahar Mohammed Zaki AbdullahDepartment of Medical Microbiology, College of Health Sciences, 125618Hawler Medical University, Erbil, Iraq.
Salah Tofik Jalal BalakyMedical Analysis Department, 605021Tishk International University, Erbil, Iraq.
Katan Sabir AliDepartment of Medical Microbiology, College of Health Sciences, 125618Hawler Medical University, Erbil, Iraq.
Mohammed Yousif MerzaMedical Analysis Department, 605021Tishk International University, Erbil, Iraq.
Shakhawan Assad KhailaniEmirates Hospital, Corona Center, Ministry of Health, Erbil, Iraq.
Nazar Pauls ShabilaDepartment of Community Medicine, College of Medicine, 125618Hawler Medical University, Erbil, Iraq.
Hawler Medical University · IQCihan University-Erbil · IQMinistry of Health · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 primarily presents as a respiratory tract infection, but studies indicate that it could be considered a systemic disease that can spread to affect multiple organ systems, including respiratory, cardiovascular, gastrointestinal, hematopoietic, neurological, and immune systems.

objectiveTo describe and analyze the clinical and hematological characteristics of 300 hospitalized COVID-19 patients in Erbil, Kurdistan.

methodsThis retrospective study included 300 patients of any age admitted to hospital due to confirmed COVID-19 between September 2020 and February 2021. Cases were diagnosed by reverse transcriptase polymerase chain reaction assays of nasopharyngeal swab specimens.

resultsThe highest proportion of patients were aged 21-40 years. The most common symptoms among the patients were myalgia (66.7%), fatigue (62.3%), headache (50.7%), and chest pain (52.7%). Differences in hematological and biochemical parameters were observed between deceased and recovered patients. Only the mid-range absolute count percentage (MID%) was significantly higher in the recovered patients than in the deceased ones (6.41% vs. 4.48,

conclusionsDifferent hematological and biochemical parameter findings were observed among the COVID-19 patients. Low MID%, older age, and presence of diabetes mellitus and chronic disease were significantly associated with death among COVID-19 patients.

Indexed as

COVID-19AdultHospitalizationHumansIraqRetrospective StudiesYoung AdultCOVID-19hematological characteristicsKurdistan Regionretrospective study

Identifiers

PMID35341332
PMCPMC8958335
OpenAlexW4220945364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.